Sherwyn Schwartz

Cetero Research is an industry leading contract research organization (CRO) in early phase research services. With more than 25 years of experience from its founding companies, Cetero has conducted more than 10,000 clinical pharmacology studies – more than any other CRO. Cetero’s proven track record allows the company to provide flexible and high quality drug development services, and its time-tested systems produce consistent and reliable data Cetero’s clients can trust. Cetero’s clinical research expertise consists of traditional early-stage, healthy-volunteer clinical pharmacology and bioavailability studies, as well as specialty Phase Ia/b trials in patients. Its bioanalytical services support clinical, preclinical drug and biomarker analysis for small and large molecules. In addition, Cetero owns and operates a full-scale central laboratory supporting Phase I-IV clinical trials in North and South America.

dgd Research is a World leader in providing relevant patient populations to meet or exceed clients' study requirements while making a positive impact on the welfare and education of its study participants. dgd Research also develops and delivers high-quality systems and services to support clinical decisions and outcomes.

American Diabetes Association provides diabetes related medical services. It funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals and the public. The company was founded in 1940 and is headquartered in Alexandria, VA.

Diabetes & Glandular Disease Research Associates, Inc., also known as dgd Research, offers treatment for hormonal and metabolic disorders such as diabetes, thyroid disease, osteoporosis, and lipid disorders. The company is based in San Antonio, TX. All physicians are board-certified in endocrinology and metabolism. The clinic was founded in 1979 with a vision to break through barriers in the healthcare industry and establish centers of excellence for diabetes treatment. The company was founded by Sherwyn L. Schwartz. Diabetes & Glandular Disease Research Associates was acquired by dgd Research, Inc. on March 08, 2006.